Oncologie Team

Our global team has deep scientific knowledge, extensive pharmaceutical experience as well as proven clinical and business acumen.

 Grand Opening New Office in Waltham, MA

Grand Opening New Office in Waltham, MA

 Garden in Souzhou

Garden in Souzhou


Oncologie Leadership

 

IMG_0078 (2).jpg

Laura Benjamin, PhD

 

Founder and CEO

BA in Biology from Barnard College, Columbia University

PhD in Molecular Biology from the University of Pennsylvania

 

Laura brings scientific vision and leadership experience from her years as faculty at Harvard Medical School and Vice President at ImClone Systems and Eli Lilly. She has focused her scientific career on cancer biology and clinical biomarker strategies.


IMG_0083.jpg

David Malek, MBA

 

Chief Business Officer

MBA from Tuck School of Management, Dartmouth University

 

 

David brings experience in business development as well as executive managerial experience in public companies, Sanofi and BiolineRx.


Hagop.jpg

Hagop Youssoufian, MD

 

Acting Chief Medical Officer

MD from University of Massachusetts Medical School

Fellowships in Genetics at Johns Hopkins and Hematology-Oncology at Massachusetts General Hospital

 

Hagop is an experienced oncology drug developer with tenures in several pharmaceutical and biotech companies, including as Chief Medical Officer at ImClone-Lilly and as President of R&D at Ziopharm. He was involved in the development and approval of multiple oncology biologic products, such as Erbitux®, Cyramza® and Taxotere®.